Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage
Viruses · 18.05.2023 · 15 (5) · 1189
DOI: 10.3390/v15051189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 18.05.2023. Verfasst von Marianne Boutin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, National Heart, Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and St….
Abstract (Originalsprache)
HIV-1 envelope glycoproteins (Envs) mediate viral entry and represent a target of choice for small molecule inhibitors. One of them, temsavir (BMS-626529) prevents the interaction of the host cell receptor CD4 with Env by binding the pocket under the β20–β21 loop of the Env subunit gp120. Along with its capacity to prevent viral entry, temsavir stabilizes Env in its “closed” conformation. We recently reported that temsavir affects glycosylation, proteolytic processing, and overall conformation of Env. Here, we extend these results to a panel of primary Envs and infectious molecular clones (IMCs), where we observe a heterogeneous impact on Env cleavage and conformation. Our results suggest that the effect of temsavir on Env conformation is associated with its capacity to decrease Env processing. Indeed, we found that the effect of temsavir on Env processing affects the recognition of HIV-1-infected cells by broadly neutralizing antibodies and correlates with their capacity to mediate antibody-dependent cellular cytotoxicity (ADCC).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.
- Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H3T 1J4, Canada.
- Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, 72076 Tübingen, Germany.
- Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany.
ORCID-Profile: Manon Nayrac, Catherine Bourassa, Daniel Sauter
Förderung
- NIAID NIH HHS
- National Institutes of Health
- National Heart, Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and St…
- National Institute of Allergy and Infectious Diseases
- CIHR Team
- Canada Foundation for Innovation
- Canada Research Chair on Retroviral Entry
Zitieren
APA
Boutin, M., Medjahed, H., Nayrac, M., Lotke, R., Gendron-Lepage, G., Bourassa, C., Sauter, D., Richard, J., & Finzi, A. (2023). Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage. Viruses, 15(5), 1189. https://doi.org/10.3390/v15051189
Vancouver
Boutin M, Medjahed H, Nayrac M, Lotke R, Gendron-Lepage G, Bourassa C, et al. Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage. Viruses. 2023;15(5):1189. doi:10.3390/v15051189
BibTeX
@article{Boutin2023,
author = {Boutin, Marianne and Medjahed, Halima and Nayrac, Manon and Lotke, Rishikesh and Gendron-Lepage, Gabrielle and Bourassa, Catherine and Sauter, Daniel and Richard, Jonathan and Finzi, Andrés},
title = {Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage},
journal = {Viruses},
year = {2023},
volume = {15},
number = {5},
pages = {1189},
doi = {10.3390/v15051189}
}
EUVIMED